|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 366.24 USD | +0.57% |
|
+3.09% | +11.89% |
| 07-21 | Amgen settles shareholder lawsuit claiming it hid $10.7 billion tax bill | RE |
| 07-20 | Goldman Sachs Adjusts Price Target on Amgen to $427 From $425, Maintains Buy Rating | MT |
Company Valuation: Amgen Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 126,718 | 140,139 | 154,142 | 140,103 | 176,250 | 197,663 | - | - |
| Change | - | 10.59% | 9.99% | -9.11% | 25.8% | 12.15% | - | - |
| Enterprise Value (EV) 1 | 151,990 | 169,779 | 207,811 | 188,229 | 221,725 | 239,335 | 234,422 | 229,145 |
| Change | - | 11.7% | 22.4% | -9.42% | 17.8% | 7.94% | -2.05% | -2.25% |
| P/E | 21.9x | 21.7x | 23.1x | 34.5x | 23x | 24x | 22x | 21.2x |
| PBR | 18.7x | 38.3x | 24.7x | 23.8x | 20.4x | 18.5x | 15.5x | 12.8x |
| PEG | - | 1.2x | 7.36x | -0.9x | 0.3x | 3.36x | 2.43x | 5.29x |
| Capitalization / Revenue | 4.88x | 5.32x | 5.47x | 4.19x | 4.8x | 5.24x | 5.11x | 4.97x |
| EV / Revenue | 5.85x | 6.45x | 7.37x | 5.63x | 6.03x | 6.34x | 6.06x | 5.77x |
| EV / EBITDA | 9.61x | 10.5x | 11.9x | 9.13x | 10.4x | 11.2x | 10.9x | 10.7x |
| EV / EBIT | 12.2x | 13.3x | 15.5x | 12.5x | 13.7x | 14.5x | 13.8x | 13.1x |
| EV / FCF | 18.1x | 19.3x | 28.2x | 18.1x | 27.4x | 18.9x | 15.5x | 15x |
| FCF Yield | 5.51% | 5.17% | 3.54% | 5.52% | 3.65% | 5.3% | 6.45% | 6.65% |
| Dividend per Share 2 | 7.04 | 7.76 | 8.52 | 9 | 9.52 | 10.09 | 10.66 | 11.12 |
| Rate of return | 3.13% | 2.95% | 2.96% | 3.45% | 2.91% | 2.75% | 2.91% | 3.04% |
| EPS 2 | 10.28 | 12.11 | 12.49 | 7.56 | 14.23 | 15.25 | 16.63 | 17.29 |
| Distribution rate | 68.5% | 64.1% | 68.2% | 119% | 66.9% | 66.2% | 64.1% | 64.3% |
| Net sales 1 | 25,979 | 26,323 | 28,190 | 33,424 | 36,751 | 37,756 | 38,690 | 39,746 |
| EBITDA 1 | 15,822 | 16,178 | 17,470 | 20,620 | 21,370 | 21,398 | 21,537 | 21,442 |
| EBIT 1 | 12,424 | 12,761 | 13,399 | 15,028 | 16,203 | 16,492 | 16,998 | 17,484 |
| Net income 1 | 5,893 | 6,552 | 6,717 | 4,090 | 7,711 | 8,219 | 8,851 | 9,284 |
| Net Debt 1 | 25,272 | 29,640 | 53,669 | 48,126 | 45,475 | 41,673 | 36,759 | 31,482 |
| Reference price 2 | 224.97 | 262.64 | 288.02 | 260.64 | 327.31 | 366.24 | 366.24 | 366.24 |
| Nbr of stocks (in thousands) | 563,266 | 533,579 | 535,178 | 537,533 | 538,481 | 539,708 | - | - |
| Announcement Date | 07/02/22 | 31/01/23 | 06/02/24 | 04/02/25 | 03/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 24.02x | 6.34x | 11.18x | 2.75% | 198B | |
| 34.93x | 12.49x | 26.13x | 0.58% | 1,048B | |
| 26.93x | 6.14x | 16.82x | 2.14% | 603B | |
| 33.36x | 7.57x | 15.52x | 2.68% | 452B | |
| 17.83x | 4.42x | 10.88x | 3% | 327B | |
| 21.97x | 5.47x | 13.3x | 2.81% | 283B | |
| 20.86x | 4.4x | 12.18x | 2% | 259B | |
| 14.29x | 5.31x | 10.95x | 3.5% | 219B | |
| -46.93x | 5.62x | 31.07x | 2.53% | 162B | |
| 12.67x | 3.1x | 7.84x | 6.92% | 142B | |
| Average | 15.99x | 6.09x | 15.59x | 2.89% | 369.38B | |
| Weighted average by Cap. | 23.69x | 7.61x | 17.81x | 2.2% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- AMGN Stock
- Valuation Amgen Inc.
Select your edition
All financial news and data tailored to specific country editions
